Daily Ards Research Analysis
Analyzed 8 papers and selected 3 impactful papers.
Summary
Personalized ventilation strategies gained momentum: a large observational analysis shows that mechanical power risk in ARDS depends on intensity, exposure duration, and lung compliance, yielding a high-performing risk-adjusted score. Physiologic metrics continue to stratify risk—an elevated Enghoff dead space fraction independently predicted hospital mortality—while a Latin American VV-ECMO program reported 70% survival, underscoring the value of specialized teams and protocols.
Research Themes
- Personalized ventilator management using risk-adjusted mechanical power
- Physiologic prognostic markers (Enghoff dead space fraction) in ventilated ICU patients
- Programmatic outcomes of VV-ECMO with specialized teams and protocols
Selected Articles
1. Power, Duration, and Compliance: Reframing Risk of Ventilatory-Induced Lung Injury With the Risk-Adjusted Mechanical-Power Score.
In 2 large ICU datasets (n=2,150 ARDS), the hazard from mechanical power depended jointly on power intensity, exposure duration, and respiratory compliance. A new risk-adjusted mechanical-power score integrating these time-varying factors achieved strong discrimination (AUC 0.863) and challenges the notion of a single safe power threshold.
Impact: Provides a clinically interpretable, time-varying score that operationalizes personalized ventilator management and redefines ventilator-induced lung injury risk quantification.
Clinical Implications: Avoid reliance on a single mechanical power threshold; consider compliance and exposure time. The risk-adjusted MP score could guide titration of tidal volume, respiratory rate, and PEEP, pending prospective validation.
Key Findings
- Risk began at 10 J/min in higher-compliance lungs with a dose-response and cumulative harm over time.
- In low-compliance lungs, risk was confined to a narrow 11–20 J/min band without cumulative harm.
- A risk-adjusted mechanical-power score integrating intensity, duration, and compliance achieved AUC 0.863.
- Analysis included 2,150 ARDS patients from Dutch and U.S. ICUs using time-dependent Cox models.
Methodological Strengths
- Time-dependent Cox modeling stratified by respiratory compliance with hour-specific exposure quantification
- Large multinational datasets with external heterogeneity and strong predictive performance (AUC 0.863)
Limitations
- Retrospective observational design with potential unmeasured confounding
- No prospective validation or interventional testing of the score; ventilator strategies may vary across sites and eras
Future Directions: Prospectively validate the risk-adjusted MP score and test protocolized, score-guided ventilation in randomized trials with patient-centered outcomes.
OBJECTIVES: Static thresholds for mechanical power (MP) may not prevent ventilator-induced lung injury because risk depends on exposure duration and the underlying respiratory compliance. We aimed to quantify how MP intensity and exposure duration interact with respiratory compliance to predict oxygenation changes consistent with acute respiratory distress syndrome worsening or 14-day mortality. DESIGN: A retrospective analysis of 2 large intensive care datasets. SETTING: ICUs in the Netherlands and the United States from 2003 to 2016 and 2008 to 2019, respectively. PATIENTS: Mechanically ventilated adults with oxygenation levels consistent with moderate to severe acute respiratory distress syndrome. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Time-dependent Cox proportional hazards models stratified by respiratory compliance estimated the hour-specific associations of immediate exceedance and cumulative time above MP thresholds with the primary outcome. Estimated effects were integrated into a risk-adjusted mechanical-power score. Among 2150 mechanically ventilated acute respiratory distress syndrome patients risk from MP exposure was dictated by respiratory compliance: in higher-compliance lungs, risk followed a dose-response pattern, with immediate hazard beginning at 10 J/min (hazard ratio = 1.04) and cumulative harm amplifying significantly over time. Conversely, for low-compliance patients, risk was confined to a narrow power band (11-20 J/min) without evidence of cumulative harm. With risk-adjusted MP score as a predictor of outcome eXtreme Gradient Boosting yielded an area under the receiver operating characteristic curve of 0.863. CONCLUSIONS: A single "safe" MP threshold is insufficient for guiding ventilation; the risk of lung injury is governed by a dynamic interplay of power intensity, duration, and the patient's respiratory compliance. The risk-adjusted MP score unifies these factors into a time-varying, clinically interpretable metric that warrants prospective validation for personalized ventilator management.
2. Prognostic value of the dead space fraction in invasive mechanical ventilation using the Enghoff equation - a single center retrospective cohort study.
In a single-center retrospective cohort of invasively ventilated adults, the Enghoff dead space fraction averaged over the first 24 hours independently associated with hospital mortality, especially when exceeding 70%. It did not predict time to extubation, supporting its role as a complementary gas exchange marker for risk stratification.
Impact: Links an easily measurable physiologic variable to mortality across ventilated ICU patients, extending prognostic utility beyond ARDS.
Clinical Implications: Consider incorporating Enghoff dead space fraction into early risk stratification alongside severity scores; values above ~70% may flag higher mortality risk and prompt closer monitoring or escalation.
Key Findings
- Higher Enghoff dead space fractions independently associated with increased hospital mortality, particularly above 70%.
- No predictive value for time until extubation despite mortality association.
- Enghoff ratio derived from volumetric capnography and arterial blood gases over the first 24 hours.
- Cox regression adjusted for APACHE IV, BMI, and gender; non-linearity modeled with restricted cubic splines.
Methodological Strengths
- Objective physiologic measurement averaged over an a priori time window with standardized acquisition (capnography and ABGs)
- Multivariable Cox modeling with adjustment for key confounders and flexible spline modeling
Limitations
- Single-center retrospective design with potential selection bias; sample size not explicitly reported
- Enghoff fraction is influenced by shunt and V/Q mismatch, potentially complicating causal interpretation
Future Directions: Validate thresholds and incremental value over established scores in multicenter cohorts; assess whether Enghoff-guided strategies improve outcomes.
BACKGROUND: The physiological dead space fraction, particularly when estimated with the Enghoff equation, reflects global gas exchange by integrating all aspects of V/Q mismatch. Elevated dead space fractions have been associated with worse outcomes in ARDS, but their prognostic value beyond ARDS remains unclear. OBJECTIVES: To evaluate the prognostic value of the dead space fraction, calculated using the Enghoff equation, for hospital mortality among critically ill patients in the ICU. STUDY DESIGN: and Methods: This single center retrospective cohort study included adults ≥18 (years) ventilated for ≥ 24 hours in the ICU of Leiden University Medical Center (October 2018 and September 2024). The Enghoff ratio was calculated from volumetric capnography and arterial blood gases, averaged over the first 24 hours. The primary outcome was hospital mortality; time until extubation was secondary. Cox regression with adjustment for APACHE IV score, Body Mass Index (BMI) and gender; non-linear effects were modeled using restricted cubic splines. RESULTS: Higher Enghoff ratios were independently associated with increased hospital mortality (Chi CONCLUSION: The Enghoff ratio was independently associated with hospital mortality in mechanically ventilated ICU patients, particularly above 70%. Although not predictive for time until extubation, it may serve as a complementary marker of gas exchange impairment and aid in risk stratification.
3. [Five years of VV ECMO for severe respiratory failure in a Latin American cardiovascular center].
A 5-year single-center VV-ECMO experience (n=20) reported 70% in-hospital survival, exceeding international series, with SARS-CoV-2 being the leading indication. Complications were frequent (acute kidney injury most common) but not directly linked to mortality; outcomes emphasize specialized teams and protocols.
Impact: Adds real-world evidence from a Latin American cardiovascular ICU showing high survival with VV-ECMO and highlighting system-level determinants of outcomes.
Clinical Implications: Supports structured VV-ECMO programs with trained teams and protocols to optimize survival in refractory respiratory failure, particularly during viral pandemics.
Key Findings
- In-hospital survival was 70%, higher than international series.
- SARS-CoV-2-related respiratory failure was the leading indication (55%).
- Comorbidities and anthropometrics were not associated with mortality.
- Acute kidney injury was the most frequent complication without direct mortality impact.
Methodological Strengths
- Standardized data collection within a specialized cardiovascular ICU and use of Kaplan-Meier survival analysis
- Real-world implementation experience over five years including COVID-19 era patients
Limitations
- Small sample size (n=20) and retrospective single-center design without a comparator group
- Potential selection bias and limited statistical power; non-significant trends in LOS and support duration
Future Directions: Prospective multicenter registries to benchmark outcomes and identify modifiable care processes; evaluate standardized protocols’ impact on complications and mortality.
BACKGROUND: Venovenous extracorporeal membrane oxygenation (VV ECMO) is a fundamental strategy in the management of refractory respiratory failure. In this context, the National Institute of Cardiology Ignacio Chávez (INCICh) has implemented VV ECMO within its cardiovascular intensive care unit (CICU). OBJECTIVE: To describe the experience and clinical outcomes of VV ECMO use in patients with severe respiratory failure in a Latin American cardiovascular center. METHOD: A retrospective observational study was conducted including patients who received VV-ECMO support at INCICh. Demographic, clinical, and hemodynamic variables, cannulation type, duration of support, complications, and hospital outcomes were analyzed. The primary outcome was in-hospital mortality. Data were analyzed using nonparametric tests and Kaplan-Meier survival curves. RESULTS: Twenty patients were included, with a median age of 41.5 years (IQR: 23-59) and a predominance of males (80%). The main indication was respiratory failure due to SARS-CoV-2 infection (55%). In-hospital survival was 70%, higher than that reported in international series. Comorbidities and anthropometric variables were not associated with mortality. Non-survivors had longer stays in the CICU, mechanical ventilation, and ECMO support, though without statistical significance. Acute kidney injury was the most frequent complication, with no direct impact on mortality. CONCLUSIONS: VV-ECMO therapy at INCICh demonstrated lower mortality compared with other series, underscoring the importance of specialized teams and established protocols to optimize outcomes in patients with refractory respiratory failure. ANTECEDENTES: La oxigenación por membrana extracorpórea (ECMO, extracorporeal membrane oxygenation) venovenosa (VV)es una estrategia fundamental en el manejo del síndrome de insuficiencia respiratoria refractaria. En este contexto, elInstituto Nacional de Cardiología Ignacio Chávez (INCICh) ha incorporado la ECMO VV en su unidad de terapia intensivacardiovascular (UTIC). OBJETIVO: Describir la experiencia y los desenlaces clínicos del uso de ECMO VV en pacientes coninsuficiencia respiratoria grave en un centro cardiovascular latinoamericano. MÉTODO: Se realizó un estudio observacionalretrospectivo de pacientes que recibieron soporte con ECMO VV en el INCICh. Se analizaron variables demográficas, clínicas, hemodinámicas, tipo de canulación, duración del soporte, complicaciones y desenlaces hospitalarios. La variable principal fue la mortalidad intrahospitalaria. Los datos fueron analizados mediante pruebas no paramétricas y curvas deKaplan-Meier. RESULTADOS: Se incluyeron 20 pacientes con mediana de edad de 41.5 años (RIQ: 23-59) y predominiomasculino (80%). La principal indicación fue insuficiencia respiratoria por SARS-CoV-2 (55%). La supervivencia intrahospitalaria fue del 70%, superior a la reportada en series internacionales. La comorbilidad y las variables antropométricas no seasociaron con la mortalidad. Los no sobrevivientes presentaron estancias más prolongadas en la UTIC, ventilación mecánicay asistencia ECMO, sin significación estadística. La lesión renal aguda fue la complicación más frecuente, sin impacto directoen la mortalidad. CONCLUSIONES: La terapia ECMO VV en el INCICh muestra una baja mortalidad comparada con otras series,destacando la relevancia de los equipos especializados y de los protocolos consolidados para optimizar los desenlaces enpacientes con insuficiencia respiratoria refractaria.